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Abstract 
Purpose: To investigate the mechanism of action by which ethanol root extract of Equisetum arvense 
influences urinary bladder activity in rats, and to characterize the major compounds of the extract.  
Methods: Ethanol (95 %) was used for hot extraction for 3 h in a Soxhlet extraction apparatus. A total of 
36 female rats were divided into Equisetum arvense root extract-treated group (EA) and control group. 
Rats in EA group were treated with a standard diet containing 0.2 % of the extract, while rats in the 
control group were fed with the diet only. After 3 weeks, 12 rats underwent cystometry with 0.2 % acetic 
acid solution and bladder activity was recorded. In another 12 rats, blood pressure, body weight and 
adenosine triphosphate were measured. In the remaining 12 rats, 0.2 % acetic acid solution was infused 
into the bladder and urinary adenosine triphosphate determined before and after the stimulation.  
Results: The results showed that during cystometry with acetic acid, the time interval between urinary 
bladder contractions was shorter and maximum bladder contraction pressure was much greater in rats 
in the control group, but in the Equisetum arvense group, the changes were much lower. Also in the 
Equisetum arvense group, plasma adrenaline and noradrenaline levels were lower than for the control 
group. Furthermore, increase in the levels of urinary adenosine triphosphate was smaller in Equisetum 
arvense group than in control group.  
Conclusion: This study suggests that Equisetum arvense ethanol root extract influences urinary 
bladder activity by decreasing adenosine triphosphate release, and is therefore a potential therapeutic 
agent against bladder disorder. However, there is need for further investigation of its exact mechanism 
of action. 
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In recent years, interest in problems related to 
urinary bladder control such as overactive 
bladder and urinary leakage is on a rapid rise. 
This increased interest may be linked to the 
increased awareness of the deleterious effect of 
lower urinary tract symptoms (LUTS) on quality 
of life as well as the World Health Organization 
(WHO) sponsored activities related to such 
issues [1]. Overactive bladder which now is 
thought to be a chronic condition is defined 
urodynamically as detrusor overactivity, and 
characterized by involuntary bladder contractions 
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during the filling phase of the micturition cycle [2]. 
Further, bladder overactivity is also reported in 
benign prostatic hyperplasia (BPH), which is a 
common condition in old men characterized by 
enlargement of the prostate gland and is 
frequently accompanied by lower urinary tract 
symptoms (LUTS) and urinary tract obstruction 
[3]. An increase in sympathetic tone and high 
blood pressure are reported to complicate LUTS. 
Further, many published studies suggest that 
ATP secreted by epithelial cells of the bladder 
also affects bladder activity.  
 
There are several reports on the efficacy and 
safety of phytotherapeutic compounds for BPH 
and LUTS. Saw Palmetto extract from Serenoa 
repens is one of the frequently studied and used 
herbal agents [4]. Further, herbal medicinal 
agents and their metabolites such as β-sitosterol, 
Pygeum (extract from Prunus africana), and 
Urtica dioica root extract. Gosha-jinki-gan, which 
is a Chinese herbal medicine has been used for 
BPH and LUTS. In animal studies using 
continuous cystometry, Gosha-jinki-gan was 
reported to increase the interval between bladder 
contractions and increase bladder capacity [5-8]. 
However, only a limited number of therapies are 
available for these urological disorders coupled 
with the drawbacks of some current therapeutic 
agents and there is a need for such therapeutic 
targets which will be effective with less toxicity. 
Therefore, the objective of this study was to 
evaluate the effect and possible mechanistic 
mechanism of action of the ethanol extract of 
Equisetum arvense on urinary bladder activity in 







A total of 36 female Sprague-Dawley rats 
(Dashuo experiment animal center, Chengdu) 
weighing 150 - 210 g were used in this study. 
The rats were divided into two groups, with a 
control group of 18 rats and an Equisetum 
arvense (EA) group of 18 rats. Rats in the control 
group were fed a standard diet, while animals in 
the EA group were fed with the same standard 
diet along with 0.2 % Equiseteum arvense 
ethanol extract powder. The rats were fed the 
respective diets for 3 weeks and tap water was 
freely accessible to them during this period. The 
animals were maintained in accordance with the 
U.S. National Institutes of Health Guide for the 
Care and Use of Laboratory Animals (NIH 
Publication 80-23, revised 1996) and all 
procedures were approved by the Ethical 
Committee of the General Hospital of Chengdu 
Military Region (approval ref no. 
IECA/GHC/2013/097).  
 
Plant material and preparation of the extract 
 
The roots of E. arvense were collected during 
May - June 2013 from Jiuzhaigou, Chengdu, 
China. The plant material was identified by Prof 
Long Qing-De of the Guiyang Medical University 
Department of Medicine, and a voucher 
specimen (no. GMU-0077654) was deposited at 
the herbarium of Guiyang Medical University, 
Guiyang, China. The roots were thoroughly 
washed with tap water, shade dried and then 
chopped into small pieces. Ethanol (95 %) was 
used for hot extraction carried out for 3 h using a 
Soxhlet extractor. The extract was then 
concentrated under reduced pressure in a rotary 
evaporator at 40 oC and was then kept in a 
refrigerator at 4 oC prior to use. 
 
Body weight measurement and continuous 
cystometry 
 
After 3 weeks of feeding, 12 rats, 6 in the control 
group and 6 in the EA group, were anesthetized 
with urethane (0.5 gm/kg and 0.3 gm/kg 
subcutaneously and intraperitoneally 
respectively) and the body weight was 
measured. To perform continuous cystometry, a 
PE-50 polyethylene catheter was injected into 
the bladder through the urethra. Physiological 
saline was infused through the catheter and 
bladder activity was measured through the 
urethral catheter, which was connected to a 
pressure transducer and a saline infusion pump 
via a 3-way stop cock. Cystometry was continued 
for at least 50 min and the interval between 
bladder contractions, maximum bladder 
contraction pressure, intravesical baseline 
pressure and bladder contraction time were 
monitored and measured during the final 30 
minutes. These rats were also subjected to 
continuous cystometry with 0.2 % acetic acid 
solution after continuous cystometry with 
physiological saline was complete. Here again, 
continuous cystometry with 0.2 % acetic acid 
solution was continued for 50 min and similar 
measurements were performed. 
 
Evaluation of biochemical profile and blood 
pressure 
 
In the other 12 rats including 6 each from the 
control and EA groups, blood pressure 
measurement and biochemical tests were carried 
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out. Blood pressure was measured in conscious 
and restrained rats by the tail cuff method using 
a BP-98A sphygmomanometer. The blood 
pressure was measured as the mean of 3 
recordings obtained at 1-min time periods. 
 
After this, each rat was anesthetized with 1.5 % 
halothane and blood was withdrawn. The blood 
sample was centrifuged followed by 
measurement of the noradrenaline, adrenaline, 
dopamine and serotonin levels in blood plasma 
using high performance liquid chromatography 
(HPLC) in combination with tandem mass 
spectrometry. 
 
Adenosine triphosphate (ATP) measurement  
 
From the remaining 12 rats, including 6 rats each 
from control group and 6 rats from EA group, 
urine samples were collected. After this, the rats 
were anesthetized with 1.5 % halothane while 2 
ml of 0.2 % acetic acid solution was infused into 
the bladder through a catheter for 15 min to 
provide stimulation. To prevent any urinary tract 
infection, the rats were injected subcutaneously 
with 100 mg cefazolin sodium hydrate. 
Spontaneously voided urine was also collected at 
3-6 h (day 0) after recovery from halothane 
anesthesia as well as on days 2, 4 and 6 after 
the bladder stimulation. Urinary ATP was 
measured using an ATP Hygiene kit HS and 
Gene Light 55. 
  
Liquid chromatography–tandem mass 
spectrometry (LC–ESI-MSMS)/HPLC analysis 
 
LC–MS equipment (LC–MS QqQ-6410B Agilent 
Technologies) consisted of a chromatographic 
system (1260 Infinity Agilent Technologies) 
coupled with an Agilent Triple Quad mass 
spectrometer fitted with an ESI source. MS 
conditions were the following: MS range 100–
1200 Da, MSn spectra were obtained using both 
positive and negative modes, nebulizer gas 45 
Psi, gas temperature 325 oC, capillary voltage 
4000 V. 
 
HPLC analysis was carried out by an Agilent 
1260 infinity series. A Chromolith RP-18e column 
(4.6 mm ID, 50 mm length) (Merck) was used. 
Mobile phase consisted of (A) aqueous formic 
acid (0.1 %) and (B) methanol. Gradient 
condition was; 0–8 min, linear gradient from 12 to 
25 % of B; 8 – 12 min, isocratic conditions at 25 
% of B; 12 – 16 min, linear gradient from 25 to 40 
% of B; 16–40 min, linear gradient from 40 to 50 
% of B, 40 – 50 min, linear gradient from 50 to 
100 % of B. Flow rate was 1 ml/min. 
Statistical analysis  
 
The results are reported as mean ± standard 
deviation (SD). Slide write Plus version 7.01 was 
used for analysis of the data while Student’s 
unpaired t-test was applied for statistical analysis 





Effect of EA on the body weight of rats 
 
There was no remarkable difference between the 
body weights of the control and EA group of rats 
before the experiment was initiated. However, 
after 3 weeks of feeding on EA diet, body weight 
of the rats in the EA group was remarkably 
increased in comparison to the control diet group 




There was no considerable difference in the time 
interval between bladder contractions, 
intravesical baseline pressure, bladder 
contraction time and residual urine volume 
between the EA group and control group rats 
during continuous cystometry with physiological 
saline. However, it is important to mention that 
maximum bladder contraction pressure was 
considerably lower by 21.7 % in the control group 
as compared to the EA group (p = 0.01, Table 1). 
However, during the continuous cystometry with 
0.2 % acetic acid solution, it was observed that 
the time interval between urinary bladder 
contractions became considerably shorter by 
18.5 % (p = 0.02) and maximum bladder 
contraction pressure was significantly higher by 
7.4 % (p = 0.01) in the control group as 
compared to the EA group (Fig 1). 
 
Biochemical profile and blood pressure 
 
It was also observed that there were no 
considerable differences in the bladder weight 
and systolic, mean and diastolic blood pressure 
between the two groups (control group and EA 
group). The biochemical tests revealed that there 
were small differences in the plasma dopamine, 
ATP and serotonin between the two groups. But 
it was revealed that plasma adrenaline and 
noradrenaline concentrations were significantly 
higher by 38.7 and 41.2 % in the control group as 
compared to the EA group (p < 0.01 and p < 
0.05, respectively, Table 2). 
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Figure 1: Intravesical infusion of E. arvense extract resulted in increased voiding frequency (decreased 
intercontraction interval). Representative continuous cystometrogram recordings in rats treated with intravesical 
protamine sulfate in control rats (A) and different concentrations of the extract (B-D). 
 
Table-1: Impact of Equisetum arvense ethanol extract on continuous cystometry with physiological   saline or 0.2 
% acetic acid 
 
Group Interval (min) 







(mean ± SD)b 
Baseline intravesical 
pressure (cm H2O) 
(Mean ± SD) c 
Duration (min) 
(mean ± SD) 
 
Physiological saline     
Control 6.2±0.9 44.2±5.4 6.4±1.3 0.9±0.3 
Equisetum arvense (EA) 8.1±1.2 51.3±8.8 7.9±1.6 0.9±0.3 
Acetic acid solution (0.2%)     
Control 3.9±1.2 48.6±1.7 5.9±1.6 0.9±0.4 
Equisetum arvense (EA) 7.3±1.7 49.3±2.1 8.1±2.1 1.3±0.3 
a p < 0.01; b p < 0.01; c p < 0.05 
 
Table-2: Effect of Equisetum arvense ethanol root extract on blood pressure and bladder weight 
 
Parameter Control 
(mean ± SD) 
Equisetum arvense  
(mean ± SD) 
Blood pressure 
(mm Hg) 
Systolic 101 ± 4 109 ± 5 
Mean 94 ± 4 97 ± 3 
Diastolic 81 ± 3 86 ± 3 
Bladder weight (g) 0.16 ± 0.03 0.15 ± 0.01 
 
Urinary ATP measurement 
 
Before acetic acid solution infusion into the 
bladder, the measured urinary ATP revealed no 
differences between the control group and EA 
group. However, after the 0.2 % acetic acid 
solution infusion into the bladder, the urinary 
ATP-to-CRE (CRE = creatinine) ratio was 
considerably higher on days 0 to 3 with a 5,556 
%, 429 % and 150 % increase in the control 
group as compared with the level before acetic 
acid infusion (p = 0.01, p < 0.001 and p < 0.05 
respectively, Fig 1 and Table 3). In the EA group, 
the urinary ATP-to-CRE ratio was also 
considerably higher on days 0 and 1 with a 3,432 
% and 150 % increase compared with that before 
acetic acid solution infusion (p < 0.01 and p < 
0.012 respectively, Fig. 1 and Table 3). However, 
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on comparing the control group with the EA 
group after acetic acid infusion, it appeared that 
the urinary ATP-to-CRE ratio was significantly 
higher on days 0 - 3 in the control group as 
compared to the EA group. However, after 6 
days the urinary ATP-to-CRE ratio shifted to 
baseline and no difference was observed 
between the two groups (control and EA group). 
 
Major compounds of extract 
 
The phytochemical analysis of the E. arvense 
root ethanol extract was carried out by LC–ESI-
MS as well as HPLC-DAD techniques.  The 
extract was run under both positive and negative 
ESI-MS conditions and it showed several major 
and minor ionic species. The seven chemical 
constituents identified were apigenin (1), luteolin 
(2), luteolin-5-O-β-D-glucopyranoside (3), 
isoquercetin (4), apigenin-5-O-glucoside (5), 
ursolic acid (6), and oleanolic acid (7) (Fig 2). 
 
These phytochemicals have already been 
reported previously in this medicinal plant [9-12]. 
The total ion MS chromatogram (TIC) and HPLC 
3-D plot are shown in Figs 3 and 4, respectively. 
The minor peaks in the chromatogram 
corresponded to some impurity with unusual 
mass fragmentation pattern, hence were not 
identified. Fragmentation of the major peaks was 
used for the identification of compounds. The 
identification of the chemical compounds was 
also carried out by comparing the molecular ion   
peaks along with the MS fragmentation pattern 





Fig 2: Phytochemical constituents identified in the ethanol root extract of Equisetum arvense 
 
    Table 3: Effect of Equisetum arvense ethanol root extract on the biochemical profile of rat  
 
Parameter Control 
(mean ± SD) 
Equisetum extract 
(mean ± SD) 
Serotonin (pg/ml)  2,186 ± 350 1,877 ± 544 
Dopamine (pg/ml)  297 ± 46 221 ± 54 
Adrenaline (pg/ml)  19,006 ± 5500 12,051 ± 3561a 
Noradrenaline (pg/ml) 2,305 ± 643 1,231 ± 321 b 
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Table 4: Effect of ethanol extract of Equisetum arvense extract on urinary ATP level after 0.2 % acetic acid 
stimulation 
 
Variable Mean ± SD ATP 
(mol/mg CRE x E-10) 
 
Control Equisetum extract P value 
Before 0.2% acetic acid 
stimulation 
12.2 ± 7.6 6.7 ± 5.4  
After 0.2% acetic acid 
stimulation  
   
Day 0 726.9 ± 432.12 321.6 ± 211.2 <0.05 
Day 1 87.1 ± 32.5 44.5 ± 21.4 >0.01 
Day 2 35.28 ± 11.6 14.31 ± 4.6 >0.01 
Day 3 32.1 ± 11.7 7.5 ± 2.7 >0.05 
Day 7 6.5 ± 3.2 2.1 ± 1.3 >0.05 









Fig 4: HPLC 3-D plot of the bioactive extract of Equisetum arvense 
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Many disorders today are being treated using 
complementary and alternative medicine, and 
consumption of herbal ingredients is on a rise 
globally, mainly due to the viewpoint that herbal 
medicines have less side-effects compared to 
orthodox medicines. Serenoa repens is one such 
herbal medicinal agent used against various 
urological disorders. Published literature reveals 
that men with BPH exhibited a significant 
improvement in the urinary peak flow rate and 
decreased nocturia after the administration of 
Serenoa repens, which is a lipid sterol extract 
from dwarf palms [13].  
 
In a one-year international study, comparing 
Serenoa repens with an α-1-adrenergic receptor 
antagonist for BPH, it was observed that both 
have an equivalent effect in men with BPH and 
LUTS for one year [14]. Another traditional 
Kampo drug called Gosha-jinki-gan, which 
comprises of 10 medicinal herbs, is also 
considered very effective for various urological 
disorders like LUTS [15,16].  
 
In one study, Gosha-jinki-gan was reported to 
increase the interval between bladder 
contractions and enhance capacity of the 
bladder. This drug is thought to have 
anticholinergic activity, which is capable of 
blocking bladder contraction induced by 
cholinergic nerve stimulation. Eviprostat, another 
herbal drug which is a cocktail of many medicinal 
plant extracts, has the effect of decreasing 
urethral pressure and increasing voided volume. 
This cocktail has also been reported to inhibit 
edema in the prostate gland and inflammation of 
the bladder mucosa in BPH patients [17]. The 
medicinal plants comprising eviprostat were 
initially used as folk medicine for many urological 
symptoms like BPH, cystitis, epididymitis, 
prostatitis etc.  
 
In this study, we have tried to delineate the 
effects of E. arvense and its influence rat bladder 
activity by carrying out a set of examinations, 
comprising of continuous cystometry, 
biochemical tests, urinary ATP and blood 
pressure measurement. No such previous 
reports are documented in the literature on this 
medicinal plant. We evaluated the changes in the 
body weight caused by the administration of EA 
diet. It was observed that on EA administration, 
plasma catecholamine concentration was 
lowered. Furthermore, plasma adrenaline and 
noradrenaline concentrations were considerably 
lower in the EA group as compared to the control 
group. During continuous cystometry with 
physiological saline, maximum bladder 
contraction pressure was significantly lower in 
the control group as compared to EA group. This 
may be due to the effect of Equisetum arvense 
on the bladder, bladder neck and urethra. The 
effect of the decrease in adrenaline, 
noradrenaline and urinary ATP levels is reflected 
in the difference between maximum bladder 
contraction pressure of control (44.2) and EA 
group (51.3).   
 
Further, in order to create a bladder inflammation 
model, 0.2 % acetic acid solution was infused 
into the bladder. With acetic acid solution 
continuous cystometry, the time interval between 
bladder contractions became significantly shorter 
and maximum bladder contraction pressure was 
much higher in the control group in comparison 
to physiological saline group. However, no 
considerable differences in the cystometric 
parameters between the infusion of physiological 
saline and 0.2 % acetic acid were observed in 
EA group. In this study, we also observed that 
EA treatment inhibits an increase in the urinary 
ATP-to-CRE ratio after bladder stimulation. It is 
also well known that acetylcholine and ATP are 
produced by bladder epithelial cells (17). It has 
also been reported recently that ATP secreted by 
bladder epithelial cells might influence bladder 
activity. Therefore, the inhibitory effect of EA on 
bladder activity may be linked to blocking ATP 
release from the bladder epithelial cells. 
Furthermore, the level of bladder activation may 
be recognized by using increased urinary ATP 
release as a marker. Equisetum arvense has 
been reported to act as a potent radical 
scavenger and these radical scavenging 
capabilities may contribute to their anti-
inflammatory action and blocking of ATP release. 
Apart from the effects of EA on bladder activity, 
photochemical analysis of EA by ESI-MS showed 
several major and minor ionic species. The 
seven chemical constituents identified were 
apigenin (1), luteolin (2), luteolin-5-O-β-D-
glucopyranoside (3), isoquercetin (4), apigenin-5-
O-glucoside (5), ursolic acid (6), and oleanolic 
acid. These will need to be evaluated for their 




The findings of this study suggest that Equisetum 
arvense ethanol root extract influences the 
urinary bladder activity by decreasing adenosine 
triphosphate release and thus can potentially be 
used as a therapeutic agent against bladder 
disorder. It may find application in the therapeutic 
efforts to reduce overactivty of urinary bladder 
which has only a limited number of therapies 
available at present. 
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